Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors
暂无分享,去创建一个
James D. Clarke | A. El-Khoueiry | B. Tran | E. Calvo | I. Garrido-Laguna | A. Cuker | A. A. Abdul Razak | Aarti Tarkar | C. Rathi | P. O’Dwyer | T. Neff | J. Rodón | Nirav Ratia | P. O'Dwyer | P. Noto | Tim Crossman